Cyclacel Pharmaceuticals- 6% PRF PERPETUAL USD 10 Net Tangible Assets

As of the most recent data (June 2026), CYCCP shows a net tangible assets of $7.2M. That compares with $3.6K in the prior-year period — up 197090.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CYCCP's net tangible assets is now $7.2M (was $3.6K) — a 197090.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Cyclacel Pharmaceuticals- 6% PRF PERPETUAL USD 10 is outperforming or lagging.

Tracking CYCCP's net tangible assets over time shows whether Cyclacel Pharmaceuticals- 6% PRF PERPETUAL USD 10 is scaling, shrinking, or reshaping that part of the business. The current reading is $7.2M That compares with $3.6K in the prior-year period — up 197090.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Cyclacel Pharmaceuticals- 6% PRF PERPETUAL USD 10's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $7.2M) with ownership activity and broader fundamentals.

Cyclacel Pharmaceuticals- 6% PRF PERPETUAL USD 10's net tangible assets is $7.2M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.